Clinical Trial Update: Clinical Trial of Rituximab in Children and Adolescents With Chronic Idiopathic Thrombocytopenic Purpura (ITP) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial evaluated rituximab in children and adolescents with chronic idiopathic thrombocytopenic purpura (ITP) and has completed Phase 1 and Phase 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Thrombocytopenic Purpura
• Immune Thrombocytopenic Purpura

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Neufeld, Ellis J, MD, PhD | Conditions: Idiopathic Thrombocytopenic Purpura (ITP), Immune Thrombocytopenic Purpura (ITP) | Phase 1, Phase 2 | Status: COMPLETED